Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • Cell Analysis

    ... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More

  • Glucose Biosensors

    ... at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of ... Read More

  • Hyperspectral Imaging Systems

    ... by 2030, growing at a CAGR of 18.6% over the analysis period 2023-2030. Cameras, one of the segments analyzed in the report, is expected to record a 19.5% CAGR and reach US$53.0 Billion by the ... Read More

  • MRI Systems

    ... at a CAGR of 5.8% over the analysis period 2023-2030. Closed MRI Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.6 Billion by the end ... Read More

  • Nucleic Acid Isolation and Purification

    ... is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected ... Read More

  • Coagulation Testing

    ... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More

  • Hemoglobin Testing

    ... at a CAGR of 5.6% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$3.0 Billion by the ... Read More

  • Histology and Cytology

    ... by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$50.6 Billion by the ... Read More

  • Oncology Molecular Diagnostics

    ... by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by ... Read More

  • Antithrombin

    ... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More

  • Therapeutic Plasma Exchange

    ... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Neurological Disorders Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million ... Read More

  • Thyroid Function Tests

    ... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by ... Read More

  • X-ray based Robots

    ... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 8.9% CAGR The X-ray based Robots market ... Read More

  • Hepatitis Test Solution/Diagnosis

    ... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. ELISA, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the ... Read More

  • In Vitro Toxicology Testing

    ... reach US$26.0 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. Cell Culture In Vitro Toxicology Testing, one of the segments analyzed in the report, is expected to record a ... Read More

  • Biological Data Visualization

    ... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Sequencing Technique, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$814.5 Million by ... Read More

  • Immunohematology Analyzers and Reagents

    ... reach US$3.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More

  • Blood Group Typing

    ... by 2030, growing at a CAGR of 9.3% over the analysis period 2023-2030. Blood Group Typing Consumables, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$2.8 ... Read More

  • Point-of-Care Diagnostics: Technologies and Global Markets

    ... and market trends, including projections through 2029 and an analysis of key players. This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including ... Read More

  • Hybrid Imaging

    ... CAGR of 4.8% over the analysis period 2023-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$4.7 Billion by the end of ... Read More

  • Medical Digital Imaging Systems

    ... 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. X-Ray Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$12.9 Billion by the ... Read More

  • Radiofrequency Ablation Devices for Pain Management

    ... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More

  • Veterinary Molecular Diagnostics

    ... at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end ... Read More

  • Umbilical Cord Blood Banking

    ... 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More

  • Industrial Digital Radiography

    ... at a CAGR of 5.7% over the analysis period 2023-2030. Computed Tomography Technology, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$543.4 Million by the end ... Read More

Cookie Settings